Vitamin D3 analogue ILX23-7553
Term · Oncology and biomedicine · MLC-T-ONC-017516
A vitamin D3 analogue with potential antineoplastic activity. ILX23-7553 binds to and activates the vitamin D receptor, a cytoplasmic polypeptide expressed in normal vitamin D responsive tissues, but also overexpressed in certain cancers including hepatocellular carcinoma and pancreatic cancer. Mediated through vitamin D receptor, this agent induces cancer cell differentiation, inhibits cancer cell growth and induces apoptosis. In addition, ILX23-7553 may also induce growth arrest and apoptosis independent of vitamin D receptor activation through mechanisms that are not fully elucidated.
| Identifier | MLC-T-ONC-017516 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 16-23-D3 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017516",
"term": "Vitamin D3 analogue ILX23-7553",
"field": "Oncology and biomedicine",
"definition": "A vitamin D3 analogue with potential antineoplastic activity. ILX23-7553 binds to and activates the vitamin D receptor, a cytoplasmic polypeptide expressed in normal vitamin D responsive tissues, but also overexpressed in certain cancers including hepatocellular carcinoma and pancreatic cancer. Mediated through vitamin D receptor, this agent induces cancer cell differentiation, inhibits cancer cell growth and induces apoptosis. In addition, ILX23-7553 may also induce growth arrest and apoptosis independent of vitamin D receptor activation through mechanisms that are not fully elucidated.",
"synonyms": [
"16-23-D3"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/vitamin-d3-analogue-ilx23-7553/"
}
Record 17,292 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.